After the online training, the number of patients who refused to take prescribed VTE prophylaxis dropped from 12.4 to 11.1%, the investigators found.

Many successful interventions have improved venous thromboembolism (VTE) prophylaxis for hospitalized patients. Yet, a significant proportion of doses of prescribed preventive medications are not ...

Nurse leaders in the nurse feedback arm received monthly scorecards detailing VTE prophylaxis administration practices by individual nurse. Credit: Journal of the American Heart Association (2022 ...

Findlay J, Keogh M, Cooper L. “Venous thromboembolism prophylaxis: the role of the nurse. British Journal of Nursing. 2010; 19(16):1028-1032. Rice KL, Walsh ME.

Venous thromboembolisms (VTE), or blood clots in the veins, affect as many as 900,000 Americans in the U.S. each year, about 50 percent of them are healthcare-associated, and as many as 70 percent ...

However, even with prophylaxis, approximately 1 in 100 patients undergoing knee replacement and 1 in 200 patients undergoing hip replacement will develop a DVT before hospital discharge. [ 3 ] ...

According to a new study published in the Canadian Journal of Cardiology, a significant number of high-risk patients are not receiving recommended venous thromboembolism (VTE) prophylaxis ...

Importantly, there was no significant difference in the rates of venous thromboembolism for patients receiving and not receiving pharmacologic prophylaxis (0.72% vs 0.86%; P = .26).

Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.

(HealthDay)—Almost all emergency general surgery (EGS) patients treated operatively and nonoperatively have increased risk of venous thromboembolism (VTE) and should receive prophylactic ...

Amid the myriad concerns that accompany a cancer diagnosis, the risk for venous thromboembolism may be last on the minds of patients and clinicians. However, substantial data demonstrate the need ...

Venous thromboembolisms (VTE), or blood clots in the veins, affect as many as 900,000 Americans in the U.S. each year, about 50 percent of them are healthcare-associated, and as many as 70 percent ...